Anticoagulating Atrial Fibrillation Patients: is There a Kidney-friendly Choice?

Overview

Journal J Thorac Dis

Publisher AME Publishing Company

Specialty Pulmonary Medicine

Date 2017 Dec 10

PMID 29221255

Authors

Chun-Yih Hsieh

Affiliations

Soon will be listed here.

References

Kalaitzidis R, Duni A, Liapis G, Balafa O, Xiromeriti S, Rapsomanikis P . Anticoagulant-related nephropathy: a case report and review of the literature of an increasingly recognized entity. Int Urol Nephrol. 2017; 49(8):1401-1407. DOI: 10.1007/s11255-017-1527-9. View

Brodsky S, Nadasdy T, Rovin B, Satoskar A, Nadasdy G, Wu H . Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int. 2011; 80(2):181-9. PMC: 3675881. DOI: 10.1038/ki.2011.44. View

Lafrance J, Miller D . Acute kidney injury associates with increased long-term mortality. J Am Soc Nephrol. 2009; 21(2):345-52. PMC: 2834549. DOI: 10.1681/ASN.2009060636. View

Sandsmark D, Messe S, Zhang X, Roy J, Nessel L, Lee Hamm L . Proteinuria, but Not eGFR, Predicts Stroke Risk in Chronic Kidney Disease: Chronic Renal Insufficiency Cohort Study. Stroke. 2015; 46(8):2075-80. PMC: 4519405. DOI: 10.1161/STROKEAHA.115.009861. View

Chan Y, Yeh Y, See L, Wang C, Chang S, Lee H . Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin. J Am Coll Cardiol. 2016; 68(21):2272-2283. DOI: 10.1016/j.jacc.2016.08.063. View

Escoli R, Santos P, Andrade S, Carvalho F . Dabigatran-Related Nephropathy in a Patient with Undiagnosed IgA Nephropathy. Case Rep Nephrol. 2015; 2015:298261. PMC: 4540981. DOI: 10.1155/2015/298261. View

Keskar V, McArthur E, Wald R, Harel Z, Zimmerman D, Molnar A . The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation. Kidney Int. 2016; 91(4):928-936. DOI: 10.1016/j.kint.2016.10.017. View

Alonso A, Lopez F, Matsushita K, Loehr L, Agarwal S, Chen L . Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2011; 123(25):2946-53. PMC: 3139978. DOI: 10.1161/CIRCULATIONAHA.111.020982. View

Brodsky S, Satoskar A, Chen J, Nadasdy G, Eagen J, Hamirani M . Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases. Am J Kidney Dis. 2009; 54(6):1121-6. DOI: 10.1053/j.ajkd.2009.04.024. View

10.

Go A, Fang M, Udaltsova N, Chang Y, Pomernacki N, Borowsky L . Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation. 2009; 119(10):1363-9. PMC: 2733238. DOI: 10.1161/CIRCULATIONAHA.108.816082. View

11.

Chan K, Giugliano R, Patel M, Abramson S, Jardine M, Zhao S . Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF. J Am Coll Cardiol. 2016; 67(24):2888-99. DOI: 10.1016/j.jacc.2016.02.082. View

12.

Ryan M, Ware K, Qamri Z, Satoskar A, Wu H, Nadasdy G . Warfarin-related nephropathy is the tip of the iceberg: direct thrombin inhibitor dabigatran induces glomerular hemorrhage with acute kidney injury in rats. Nephrol Dial Transplant. 2013; 29(12):2228-34. DOI: 10.1093/ndt/gft380. View

13.

Connolly S, Ezekowitz M, Yusuf S, Eikelboom J, Oldgren J, Parekh A . Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009; 361(12):1139-51. DOI: 10.1056/NEJMoa0905561. View

14.

Olesen J, Lip G, Kamper A, Hommel K, Kober L, Lane D . Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med. 2012; 367(7):625-35. DOI: 10.1056/NEJMoa1105594. View

15.

Ruff C, Giugliano R, Braunwald E, Hoffman E, Deenadayalu N, Ezekowitz M . Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2013; 383(9921):955-62. DOI: 10.1016/S0140-6736(13)62343-0. View

16.

Chawla L, Kimmel P . Acute kidney injury and chronic kidney disease: an integrated clinical syndrome. Kidney Int. 2012; 82(5):516-24. DOI: 10.1038/ki.2012.208. View

17.

Bohm M, Ezekowitz M, Connolly S, Eikelboom J, Hohnloser S, Reilly P . Changes in Renal Function in Patients With Atrial Fibrillation: An Analysis From the RE-LY Trial. J Am Coll Cardiol. 2015; 65(23):2481-93. DOI: 10.1016/j.jacc.2015.03.577. View

18.

Golbin L, Vigneau C, Touchard G, Thervet E, Halimi J, Sawadogo T . Warfarin-related nephropathy induced by three different vitamin K antagonists: analysis of 13 biopsy-proven cases. Clin Kidney J. 2017; 10(3):381-388. PMC: 5466118. DOI: 10.1093/ckj/sfw133. View

19.

Limdi N, Beasley T, Baird M, Goldstein J, McGwin G, Arnett D . Kidney function influences warfarin responsiveness and hemorrhagic complications. J Am Soc Nephrol. 2009; 20(4):912-21. PMC: 2663833. DOI: 10.1681/ASN.2008070802. View

20.

An J, Ahn S, Yoon C, Youn T, Han M, Kim S . The occurrence of warfarin-related nephropathy and effects on renal and patient outcomes in korean patients. PLoS One. 2013; 8(4):e57661. PMC: 3613349. DOI: 10.1371/journal.pone.0057661. View